BYD autonomous vehicle software and hardware were announced on Feb 10 2025 and demonstrate that autonomous driving is rapidly advancing and the majority of vehicles during the next 3 years will be capable of becoming robotaxis, enabling personal public transport to extend not just from 60 cities to globally.
AI is driving a rapid advances in robotaxis and autonomous driving. Like many new technologies this has taken 70 years, and in less than 5 years will see all cars with full autonomy with the advances in AI and with electric vehicles now cheaper than internal combustion engines
AI will help us live longer than we every expected. Not just to 120. We may be able to live to hundreds. We are in the midst of a healthspan revolution that will enable us to live vitally. Advanced diagnostics to catch any disease at inception. Tailored advanced therapies to reverse disease. Slowing, stopping, and potentially even reversing aging.
Human 3D organoids are in vitro 3D cultures that mimic the structure and function of human organs. They are derived from stem cells, which can self-renew and differentiate into various cell types. Organoids are a powerful in disease modelling, drug development, personalised treatment, and regenerative medicine.
The tone of Tesla’s earnings call for Q4-2024 and full year 2024 today was cautiously optimistic, with Elon Musk emphasizing a significant focus on autonomy and future growth. Despite some disappointing financial results, there was a bullish outlook on AI, FSD, and new vehicle launches, coupled with Musk’s characteristic confidence in Tesla’s future value.
Nano-silicon anodes are a promising new technology for lithium-ion batteries. They offer 30% superior capacity, faster charging and longer life than traditional graphite anodes. Group 14 is a leading company in this field, and their technology is already being used in smartphones. They are now expanding their production to meet the growing demand for batteries in electric vehicles and other applications.
AI continues to rapidly expand. At CES, 2025 Nvidia announcements include a new AI supercomputer, a powerful video card, next-generation processor for cars and robots. NVidia announced partnerships with Toyota for next model robotasis as well as Aurora, Continental for driverless trucks at scale by 2027.
AI is transforming clinical trials by predicting success with 90% accuracy. This could lead to fewer trials, better outcomes, and reduced trial times. Companies like OPYL, OpenAI, and Moderna are at the forefront of this AI-driven healthcare revolution. Using 20 years of past clinical trial data, OPYL can improve trial outcomes by 4 to 5 times, reducing costs and improving success.
Within a decade we will cure disease, not just treat it. AI accelerates drug discovery and will reduce cost of new drugs by 4 from $2.4 billion to $600 million, and time from 14 years to 6 years. ROI improves 12 times. AI in medicine will not just improve medicines but will improve diagnosis and treatment.
Most research shows Mistrust in science increasing over the past decades and primarily driven by political polarization, amplified by partisan media and social media algorithms that spread misinformation, with variation observed across age, rural vs. urban populations, and political affiliations. Was it the nuclear bomb, or Rachael Carson, but mistrust is increasing rapidly.
